Physician profile
Lee R Goldberg
NPI 1144250259
$129,518.20
in general payments reported to CMS, 2019-2025
15 companies · $4,068 in 2025
The $4,068 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $24K · 2021: $18K · 2022: $28K · 2023: $21K · 2024: $14K · 2025: $4,068.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Travel and Lodging: $9,507 · Food and Beverage: $3,328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,808.47 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,200.00 |
| Travel and Lodging | $9,506.57 |
| Food and Beverage | $3,327.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $77,447.00 | 2019-2025 | Remede System |
| Abbott Laboratories | $27,695.04 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Edwards Lifesciences Corporation | $16,909.92 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $5,992.60 | 2019-2023 | |
| Medtronic Vascular, INC. | $760.79 | 2019 | |
| Itamar Medical INC | $145.87 | 2023 | Watchpatone |
| Kestra Medical Technology Services, INC. | $122.06 | 2022-2025 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $117.73 | 2023-2025 | Optimizer, Optimizer |
| Abiomed | $104.49 | 2022-2023 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $68.05 | 2023-2024 | Lifevest |
| Esperion Therapeutics, INC. | $51.71 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $38.67 | 2024 | |
| Boston Scientific Corporation | $25.00 | 2023 | Watchman Access System |
| Irhythm Technologies, INC. | $22.31 | 2019 | |
| Merck Sharp & Dohme LLC | $16.96 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.